The value of biomarkers in the therapy of CRSwNP with biologicals-a long-term follow-up of dupilumab therapy. Sarnoch SO, Pepic A, Schmitz L, Becker B, et al. Eur Arch Otorhinolaryngol 2024;281:4789-4805.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sarnoch SO, Pepic A, Schmitz L, Becker B, et al. The value of biomarkers in the therapy of CRSwNP with biologicals-a long-term follow-up of dupilumab therapy. Eur Arch Otorhinolaryngol 2024;281:4789-4805.
PMID: 38709320